After thirteen years leading the Department of Pharmaceutics to international success, Professor Kenneth Thummel will return to faculty full time and Professor Nina Isoherranen will become the Milo Gibaldi Endowed Chair of Pharmaceutics.
Dr. Thummel was appointed Chair of the Pharmaceutics Department in 2006. He assumed that role from the Department’s founding Chair, Dr. Rene’ Levy and was the first Milo Gibaldi Endowed Chair of Pharmaceutics.
In his leadership role as chair, Dr. Thummel made substantial scientific and administrative contributions to the department and the field of Pharmaceutics.
“I am grateful to Ken for his leadership and collaboration over the years. His impact on the School, our students, and alumni is profound. His mentorship and life-changing research have had a profound impact on the School, the Northwest, and around the world—and even outer space.”—Sean D. Sullivan, Professor and Dean, UW School of Pharmacy
At the time of his appointment, the Department consisted of 7 full time faculty, 5 temporary or part-time faculty, 16 post-doctoral fellows, 20 graduate students and a limited number of research and instructional support staff. Its annual extramural funding totaled approximately $2.7 million.
As he steps down as Chair, the Department’s annual research funding stands at $13.6 million (2018), with over 100 departmental personnel working collectively to meet instructional, research and service missions. These successes are a key reason why the UWSOP is ranked #3 nationally among Schools of Pharmacy in NIH grant awards
The Department of Pharmaceutics also is recognized as a leader in drug-drug interaction science and the faculty are innovators in targeted drug delivery, physiologically-based pharmacokinetic modeling and microphysiologic human organ systems. Under the leadership of Dr. Isabelle Ragueneau, the Drug Interaction Solutions (formerly Drug Interactions Database) database team produces a commercialized software product licensed by the University to pharmaceutical companies and other academic and clinical programs worldwide. The database produces annual revenue in excess of $1.0 million and supports graduate student training in the pharmaceutical sciences arena.
To ensure the continued outstanding research and training in the Department of Pharmaceutics, we invite you to support the Pharmaceutics Fund for Excellence.
To study with researchers like Pharmaceutics’ Professors Nina Isoherranen and Kenneth Thummel, click on the links for more information about our Graduate Programs in Medicinal Chemistry, Pharmaceutics, Pharmaceutical Outcomes Research and Policy, and Biomedical Regulatory Affairs.